Answers are grounded in this paper and cite their sources.
The authors clarify that in their meta-analysis, trials were classified by the primary first-line treatment strategy, acknowledging that supplemental drugs were often used in a stepped-care approach.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bruce M. Psaty (1997) conducted a letter in Cardiovascular Disease. β-Blockers was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: